期刊文献+

中西医结合治疗川崎病的临床效果 被引量:1

Clinical effect of integrated traditional Chinese and western medicine treatment on Kawasaki disease
下载PDF
导出
摘要 目的探讨中西医结合治疗与单纯西医治疗川崎病的临床效果。方法选取我院收治的川崎病患儿109例,按单双号分为治疗组(55例)和对照组(54例)。对照组患儿给予静脉注射小剂量(400 mg/kg.d)免疫球蛋白(IVIG)与口服阿司匹林。治疗组患儿在对照组的基础上尽早加用中医中药。比较两组患儿的临床治疗效果及并发症发生率。结果 109例川崎病患儿均随访6个月,治疗组患儿3 d后体温恢复率、1周后白细胞计数恢复率及C反应蛋白恢复率、2~3周后血小板及血沉恢复率明显高于对照组,1~6个月后冠状动脉病变、心肌损伤发生率明显低于对照组(P<0.05)。结论中西医结合治疗川崎病临床效果明显优于单纯西医治疗。 Objective To investigate of clinical effect of integrated traditional Chinese and western medicine treatment on Kawasaki disease. Methods A total of 109 Kawasaki disease patients admitted in our hospital were selected and divided into treatment group(n=55) and control group(n=54) according to even and add-numbered license plate. The control group was treated withimmunoglobulin(IVIG) and aspirin, and the treatment group was given traditional Chinese medicine on the basis of the control group. The clinical effects and incidence rates of the two groups were compared. Results All the 109 Kawasaki disease patients were followed up for 6 months, the body temperature recovery rate after 3 days, white blood cell count and C-reactive protein recovery rates after 1 week, platelet and blood sedimentation recover rates at 2-3 weeks and the incidence rate of coronary artery disease and myocardial injury of the treatment group were better than those of the control group(P〈0.05). Conclusion The clinical effect of integrated traditional Chinese and western medicine treatment on Kawasaki disease is better than conventional western medicine treatment.
出处 《临床医学研究与实践》 2017年第17期123-124,共2页 Clinical Research and Practice
关键词 川崎病 中西医结合 儿科 Kawasaki disease integrated traditional Chinese and western medicine treatment pediatric
  • 相关文献

参考文献5

二级参考文献71

  • 1楚奇.记“五四”老人郑南宣[J].武汉文史资料,2000,0(5):18-21. 被引量:2
  • 2张永兰,杜忠东.川崎病并发冠状动脉损害的危险因素[J].国际儿科学杂志,2006,33(2):93-96. 被引量:23
  • 3林忠东,焦颖,李光乾.儿童川崎病合并无菌性脑膜炎临床特点分析[J].中国小儿急救医学,2006,13(3):256-257. 被引量:4
  • 4沈晓明,王卫平.儿科学.7版,北京:人民卫生出版社,2008:133. 被引量:26
  • 5Rowley AH. Shulman ST.Pathogenesis and management of Kawasaki diseaselJ1. Expert Rev Anti lnfe'ct Ther,2010,8 ( 2 ): 197-203. 被引量:1
  • 6Priett Tato LM. Cuesta Rubi MT, Guill 6 a Mart f n S.Kawasaki disease: l)iagnsis and trealmen/[J].An Pdiatr ( Bare ), 2010,73 ( 1 ) : 25-30. 被引量:1
  • 7Lee TJ, Kim KH, Chun JK, et al.l,w-dose methotrexate therapy for intravenous immun{glohulin-resistant kawasaki disease[J1.Yonsei Med J,2008,49 ( 5 ): 714-718. 被引量:1
  • 8Burns JC, Besl BM. Mejias A, et al.lnfliximai lreatment of intravenous ilnmunoglobulin-resistanl Kawasaki diseasP[Jl.J Pediatr,2008,153 ( 6 ): 833-888. 被引量:1
  • 9S . ve P, Lega JC.Kawasaki disease in aduh patienls[J].Rev Med Interne, 2011, .32 (1 ): 17-25. 被引量:1
  • 10Tsuda E, Abe T, Tamaki W.Acme coronary syndrome in adull palienls wilh coronary mten.' lesions caused by Kawasaki diase: review of case reporls[J]. Cardiol Young,2011,21 ( 1 ) : 74-82. 被引量:1

共引文献60

同被引文献7

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部